Scan beyond Darling Ingredients and explore how other specialty ingredient and renewable fuel players are positioned using our curated list of 21 high quality undiscovered gems for this corner of the market.
To stay in Darling Ingredients, you really need to believe that the combination of renewable fuels and higher margin collagen keeps generating healthy EBITDA and cash. The solid Diamond Green Diesel quarter and US$2.2b to US$2.3b 2026 Combined Adjusted EBITDA guidance support that operating story. The near term catalyst is the October 29 earnings call. The key risk remains regulatory or margin pressure in renewable diesel.
Short term, the question is whether cash generation can stay strong enough to fund deleveraging and any future capital returns without stretching the balance sheet, especially with interest coverage flagged as weak. Any disappointment around Fuel segment profitability or slower progress in mix shifting toward specialty ingredients could challenge that narrative.
The launch of Nextida NxCogni looks most relevant for the collagen and health focused side of Darling Ingredients. It builds on the Nextida platform that already includes Nextida GC, which targets GLP 1 related blood glucose support and is patented across several regions. Investors watching margin mix will likely focus on whether products like NxCogni scale inside the Food Ingredients segment.
If uptake is solid, this kind of neurosupportive collagen could help push more volume into categories that are described as earning several times traditional gelatin margins. That would matter for the medium term catalyst around expanding EBITDA from existing assets, especially alongside management’s stated focus on contract repricing and efficiency rather than heavy new capex.
Darling Ingredients' current analyst narrative points to revenues of US$7.3b and earnings of US$864.7 million by 2029, built on assumed 3.7% yearly revenue growth and an earnings increase of about US$266.8 million from US$597.9 million today.
Uncover why Darling Ingredients' fair value indicates a 46% potential upside to its current price that could narrow quickly.
Some of the most optimistic analysts focus on a very different catalyst for Darling Ingredients. They emphasize a larger buildout of rendering and collagen plants, and already had pre-news forecasts near US$7.4b of revenue and about US$879.8 million of earnings by 2029. You can treat the NxCogni launch as a fresh test of those stronger views.
Explore 5 other Darling Ingredients fair value estimates, including one that suggests as much as 135% potential upside from the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Once you have formed a view on Darling Ingredients, it helps to cross check that thinking against a broader watchlist of opportunities with different risk and income profiles.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com